Back
Lululemon Athletica Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
62
LULU
Lululemon Athletica
Last Price:
318.52
Seasonality Move:
6.19%
Buy
51
APLS
Apellis Pharmaceuticals
Last Price:
29.61
Seasonality Move:
22.1%
Buy
62
Lululemon Athletica (LULU)
is a Buy
Is Lululemon Athletica a Buy, Sell or Hold?
- The current Lululemon Athletica [LULU] share price is $308.64. The Score for LULU is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- LULU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $30.02. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LULU Stock Price Chart
What is Lululemon Athletica's stock price today?
-
The Lululemon Athletica share price today is $308.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LULU is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $30.02
The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LULU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.47 | Buy |
| Relative Strength Index (14 RSI): | 58.13 | Buy |
| Chaikin Money Flow: | -1680269 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (280.95 - 311.73) | Buy |
| Bollinger Bands (100): | (253.38 - 299.66) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 58.06 | Buy |
| Chaikin Money Flow: | 2150169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.93 - 28.43) | Buy |
| Bollinger Bands (100): | (29.7 - 39.56) | Sell |
LULU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 312.19 | Sell |
| 20-day SMA: | 302.07 | Buy |
| 50-day SMA: | 279.13 | Buy |
| 200-day SMA: | 333.45 | Sell |
| 8-day EMA: | 311.12 | Sell |
| 20-day EMA: | 301.95 | Buy |
| 50-day EMA: | 288.23 | Buy |
| 200-day EMA: | 318.22 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.4 | Buy |
| 20-day SMA: | 27.8 | Buy |
| 50-day SMA: | 31.23 | Sell |
| 200-day SMA: | 44.21 | Sell |
| 8-day EMA: | 28.61 | Buy |
| 20-day EMA: | 28.43 | Buy |
| 50-day EMA: | 30.68 | Sell |
| 200-day EMA: | 40.64 | Sell |
Lululemon Athletica Earnings Growth & LULU Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.53 per share, and an increase next year of $1.60 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Lululemon Athletica Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||